Ying Leng

2.9k total citations
103 papers, 2.5k citations indexed

About

Ying Leng is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Oncology. According to data from OpenAlex, Ying Leng has authored 103 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 58 papers in Molecular Biology, 42 papers in Endocrinology, Diabetes and Metabolism and 18 papers in Oncology. Recurrent topics in Ying Leng's work include Hormonal Regulation and Hypertension (20 papers), Diabetes Treatment and Management (18 papers) and Metabolism, Diabetes, and Cancer (13 papers). Ying Leng is often cited by papers focused on Hormonal Regulation and Hypertension (20 papers), Diabetes Treatment and Management (18 papers) and Metabolism, Diabetes, and Cancer (13 papers). Ying Leng collaborates with scholars based in China, Sweden and United States. Ying Leng's co-authors include Yu Shen, Ying Feng, Mengmeng Ning, Jianhua Shen, Suling Huang, Yangliang Ye, Jian‐Min Yue, Lina Zhang, Ji‐Kai Liu and Tatiana L. Steiler and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Biological Chemistry and Diabetes.

In The Last Decade

Ying Leng

101 papers receiving 2.4k citations

Peers

Countries citing papers authored by Ying Leng

Since Specialization

Citations

This map shows the geographic impact of Ying Leng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ying Leng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ying Leng more than expected).

Fields of papers citing papers by Ying Leng

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ying Leng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ying Leng. The network helps show where Ying Leng may publish in the future.

Co-authorship network of co-authors of Ying Leng

This figure shows the co-authorship network connecting the top 25 collaborators of Ying Leng. A scholar is included among the top collaborators of Ying Leng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ying Leng. Ying Leng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A novel TGR5 agonist Sauchinone ameliorates IMQ induced murine psoriasis by regulating macrophage polarization 2025 ·Journal of Advanced Research ·Haoyu Wang, Suling Huang, Jing Ren, Li‐Yan Peng, (unknown), Ling Qi, Ke Zhu, Chunlan Feng, Rong Zhou, (unknown), Lu Cao, Ying Leng, Qin‐Shi Zhao, Wei Tang	0
2	Design, synthesis and biological evaluation of Alisol B derivatives for potential treatment of non-alcoholic steatohepatitis 2025 ·Bioorganic Chemistry ·(unknown), Suling Huang, (unknown), Jiayue Wang, Yu Shen, Ying Leng, Qin‐Shi Zhao	2
3	TGR5 agonist inhibits intestinal epithelial cell apoptosis via cAMP/PKA/c-FLIP/JNK signaling pathway and ameliorates dextran sulfate sodium-induced ulcerative colitis 2023 ·Acta Pharmacologica Sinica ·(unknown), (unknown), (unknown), Hui Qu, Jia Liu, Jianhua Shen, Ying Leng	30
4	Design, synthesis and structural-activity relationship studies of phanginin A derivatives for regulating SIK1-cAMP/CREB signaling to suppress hepatic gluconeogenesis 2022 ·European Journal of Medicinal Chemistry ·Xing‐De Wu, Suling Huang, Yu Shi, (unknown), (unknown), Ying Leng, Qin‐Shi Zhao	9
5	Phenotypic screening-based drug discovery of furan-2-carboxylic acid derivatives for the amelioration of type 2 diabetes mellitus (T2DM) 2022 ·European Journal of Medicinal Chemistry ·Lili Chen, Suling Huang, Yangliang Ye, Yu Shen, (unknown), Li Qin, Lili Du, Ying Leng, Jianhua Shen	1
6	Discovery of novel ketoxime ether derivatives with potent FXR agonistic activity, oral effectiveness and high liver/blood ratio 2021 ·Bioorganic & Medicinal Chemistry ·(unknown), Mengmeng Ning, Yangliang Ye, (unknown), (unknown), Ying Leng, Jianhua Shen	5
7	Design of G-protein-coupled bile acid receptor 1 (GPBAR1, TGR5) soft drugs with reduced gallbladder-filling effects 2020 ·European Journal of Medicinal Chemistry ·(unknown), Mengmeng Ning, Hua Cao, Yangliang Ye, Ying Feng, Ying Leng, Jianhua Shen	8
8	Synthesis of selective 11 β -HSD1 inhibitors based on dammarane scaffold 2017 ·European Journal of Medicinal Chemistry ·Li‐Dong Shao, Ying Bao, Yu Shen, Jia Su, Ying Leng, Qin‐Shi Zhao	7
9	Analysis of diacylglycerols by ultra performance liquid chromatography-quadrupole time-of-flight mass spectrometry: Double bond location and isomers separation 2016 ·Analytica Chimica Acta ·Pan Deng, Dafang Zhong, Xi Wang, (unknown), Lei Zhou, Ying Leng, Xiaoyan Chen	14
10	OL3, a novel low-absorbed TGR5 agonist with reduced side effects, lowered blood glucose via dual actions on TGR5 activation and DPP-4 inhibition 2016 ·Acta Pharmacologica Sinica ·(unknown), Mengmeng Ning, (unknown), Ying Feng, Yangliang Ye, Jianhua Shen, Ying Leng	24
11	16-nor Limonoids from Harrisonia perforata as promising selective 11β-HSD1 inhibitors 2016 ·Scientific Reports ·Xiaohui Yan, Ping Yi, Pei Cao, Shiying Yang, Xin Fang, Yu Zhang, Bin Wu, Ying Leng, Ying‐Tong Di, Yang Lv, Xiao‐Jiang Hao	16
12	SHR3824, a novel selective inhibitor of renal sodium glucose cotransporter 2, exhibits antidiabetic efficacy in rodent models 2014 ·Acta Pharmacologica Sinica ·Pangke Yan, Lina Zhang, (unknown), Hui Qu, Li Qin, Lianshan Zhang, Ying Leng	10
13	Emodin, an 11β-hydroxysteroid dehydrogenase type 1 inhibitor, regulates adipocyte function in vitro and exerts anti-diabetic effect in ob/ob mice 2012 ·Acta Pharmacologica Sinica ·(unknown), Suling Huang, Ying Feng, Mengmeng Ning, Ying Leng	39
14	Design, synthesis, and pharmacological evaluation of N-(4-mono and 4,5-disubstituted thiazol-2-yl)-2-aryl-3-(tetrahydro-2H-pyran-4-yl)propanamides as glucokinase activators 2010 ·Bioorganic & Medicinal Chemistry ·Fuying Li, Qingzhang Zhu, Yi Zhang, Ying Feng, Ying Leng, Ao Zhang	39
15	Emodin, a natural product, selectively inhibits 11β‐hydroxysteroid dehydrogenase type 1 and ameliorates metabolic disorder in diet‐induced obese mice 2010 ·British Journal of Pharmacology ·Ying Feng, Suling Huang, (unknown), Song Zhang, (unknown), Yu Shen, (unknown), Ying Leng	103
16	4-(Phenylsulfonamidomethyl)benzamides as potent and selective inhibitors of the 11β-hydroxysteroid dehydrogenase type 1 with efficacy in diabetic ob/ob mice 2009 ·Bioorganic & Medicinal Chemistry Letters ·Xu Zhang, Zhou Zhou, Huaiyu Yang, Junhua Chen, Ying Feng, Lili Du, Ying Leng, Jianhua Shen	13
17	Pentanol derivatives from basidiomycete Catathelasma imperiale and their 11β-hydroxysteroid dehydrogenases inhibitory activity 2009 ·The Journal of Antibiotics ·Ling Zhang, Yu Shen, Hua‐Jie Zhu, Fei Wang, Ying Leng, Ji‐Kai Liu	13
18	Structure-based virtual screening for identification of novel 11β-HSD1 inhibitors 2008 ·European Journal of Medicinal Chemistry ·Huaiyu Yang, Yu Shen, Junhua Chen, (unknown), Ying Leng, Jianhua Shen	33
19	Antidiabetic effect of a novel non-thiazolidinedione PPAR ?/? agonist on ob/ob mice 2006 ·Acta Pharmacologica Sinica ·Xi Hu, Ying Feng, Yu Shen, Xiaofeng Zhao, (unknown), Yushe Yang, Ying Leng	15
20	The effect of Nestorone on gonadotropic cells in pituitary of rats 2004 ·Contraception ·Xiaofeng Zhao, (unknown), Yanling Wang, Ying Leng, Lin Cao, (unknown), Zhiping Gu	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact